These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1210456)

  • 1. [Anamnesis as a screening method for cardiovascular diseases].
    Bohm R; Heinemann L; Günther KH; Linss G; Heine H
    Z Gesamte Inn Med; 1975 Jul; 30(14):127-8. PubMed ID: 1210456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of a computer for the preparation of medical history screening in cardiovascular diseases].
    Bohm R; Heinemann L; Schmidt J; Heinrich K; Richter R; Läuter J
    Z Gesamte Inn Med; 1977 Sep; 32(18):suppl 282-3. PubMed ID: 339567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic diagnosis of cardiovascular diseases--value of the combined use of a standardized anamnesis and blood pressure measurement].
    Bohm R; Günther KH; Petzschmann S; Läuter J
    Z Arztl Fortbild (Jena); 1987; 81(19):1003-5. PubMed ID: 3439212
    [No Abstract]   [Full Text] [Related]  

  • 4. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective.
    Valdez R; Greenlund KJ; Khoury MJ; Yoon PW
    Pediatrics; 2007 Sep; 120 Suppl 2():S78-86. PubMed ID: 17767009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Occupational anamnesis in primary care medicine: presentation of a screening questionnaire for health problems related to work].
    Wasem L; Verdon F; Holtz J; Decrey H; Boillat MA
    Rev Med Suisse Romande; 2001 Nov; 121(11):845-9. PubMed ID: 11765571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular screening.
    Kelly HB
    Practitioner; 1981 May; 225(1355):625-30. PubMed ID: 7291116
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pre-participation screening of individuals engaging in noncompetitive physical activity].
    Scheinowitz M; Dankner R; Goldbourt U; Marom-Klibansky R
    Harefuah; 2008 Jul; 147(7):611-7, 662, 661. PubMed ID: 18814521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stage-by-stage diagnosis in conducting the cardiological screening of servicemen using a computer].
    Iakovlev GM; Ermolaev VI; Liubovskiĭ IA; Chernenko GE
    Voen Med Zh; 1992 Nov; (11):32-5, 80. PubMed ID: 1481424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Qualification of anamnestic data for cardiovascular screening].
    Heinemann L; Bohm R; Günther KH; Heine H
    Z Gesamte Inn Med; 1975 Aug; 30(15):129-31. PubMed ID: 1189488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complaint profile and anamnesis in the hypertensive patient].
    Kiesewetter R; Helbig B; Herrmann RM
    Z Gesamte Inn Med; 1980 Sep; 35(18):713-6. PubMed ID: 7445614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular evaluation of the worker and workplace: a practical guide for clinicians.
    Belkić K; Schnall P; Ugljesić M
    Occup Med; 2000; 15(1):213-22, iv. PubMed ID: 10702086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB; Latsch J; Bjarnason-Wehrens B; Albus C; Falkowski G; Herold G; Mey E; Heinzler R; Montiel G; Schneider CA; Stützer H; Türk S; Weisbrod M; Predel HG
    Z Kardiol; 2004 Feb; 93(2):131-6. PubMed ID: 14963679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Automated collection of the anamnesis in mass screenings (the example of oncological screening)].
    Zaseev VK; Mikhlin BS; Shubin BM; Shul'meĭster AG
    Med Tekh; 1981; (6):52-4. PubMed ID: 7033721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the health of Oklahomans through clinical prevention, part II: Screening to identify early-stage disease and risk factors.
    Crutcher JM; DeRose DJ; DePersio SR
    J Okla State Med Assoc; 2000 Aug; 93(8):397-408. PubMed ID: 10979617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hospital-wide vascular screening program at the University Medical Center, Utrecht: prevalence of risk factors and asymptomatic vascular disease from 1996 to 2002].
    Visseren FL; de Jaegere PP; Banga JD; Kappelle LJ; Eikelboom BC; Mali WP; Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2376-82. PubMed ID: 14677480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for major cardiovascular risk factors among Members of Polish Parliament as a continuation of health marketing for effective cardiovascular prevention in Poland. Warsaw, May 2006.
    Rutkowski M; Zdrojewski T; Bandosz P; Wierucki L; Piwoński J; Piwońska A; Narkiewicz K; Opolski G; Drygas W; Korewicki J; Wyrzykowski B
    Kardiol Pol; 2007 May; 65(5):486-92; discussion 493-4. PubMed ID: 17577845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for cardiovascular risk factors in public screening programs: are target groups being reached?].
    Kalker U; Leppek S; Peters M
    Offentl Gesundheitswes; 1991; 53(8-9):604-5. PubMed ID: 1837906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension management in primary care: standard care and attitude towards a disease management model.
    Wassenberg MW; Willemsen JM; Gaillard CA; Braam B
    Neth J Med; 2004 Nov; 62(10):375-82. PubMed ID: 15683092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevention and screening of cardiovascular disease: an update.
    Selig PM
    Nurse Pract Forum; 1991 Mar; 2(1):14-8. PubMed ID: 1840928
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the cardiovascular system at the workplace.
    Schnall P; Belkić K; Pickering TG
    Occup Med; 2000; 15(1):189-212. PubMed ID: 10702085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.